Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Ovarian Cysts Treatment & Management

  • Author: C William Helm, MBBCh, MA, FRCS(Edin), FRCS; Chief Editor: Michel E Rivlin, MD  more...
 
Updated: Feb 12, 2015
 

Approach Considerations

Epidemiologic studies from the 1970s-1990s reported inverse relationships between oral contraceptive pill (OCP) use and surgically confirmed functional ovarian cysts. Short-term treatment with OCPs was thus used for initial management of ovarian cysts.

However, meta-analyses have since shown that there is no difference between OCP use and placebo in terms of treatment outcomes in ovarian cysts and that these masses should be monitored expectantly for several menstrual cycles. If a cystic mass does not resolve after this timeframe, it is unlikely to be a functional cyst, and further workup may be indicated.[41]

Many patients with simple ovarian cysts based on ultrasonographic findings do not require treatment. In a postmenopausal patient, a persistent simple cyst smaller than 5cm in dimension in the presence of a normal CA125 value may be monitored with serial ultrasonographic examinations.[3] {[63] Some evidence suggests that cysts up to 10cm can be safely followed in this way.

Premenopausal women with asymptomatic simple cysts smaller than 8cm on sonograms in whom the CA125 value is within the reference range may be monitored, with a repeat ultrasonographic examination in 8-12 weeks. Hormone therapy, including, as stated above, the use of the OCPs, is not helpful in resolving the cyst.[41]

Next

Fetal and Neonatal Cysts

In female newborns, ovarian cysts are the most frequent type of abdominal tumor, with an estimated incidence of more than 30%.[19, 14]

Fetal ovarian cysts are believed to be caused by hormonal stimulation, such as fetal gonadotropins, maternal estrogen, and placental hCG. In addition, an association between fetal ovarian cysts and maternal diabetes and fetal hypothyroidism has been identified.

Most fetal ovarian cysts are small and involute within the first few months of life and are not of clinical significance. They are generally diagnosed in the third trimester of pregnancy, and most tend to resolve at 2-10 weeks postnatally.[14]

Differential diagnoses of these cysts include urachal cysts, intestinal duplication abnormalities, cystic teratoma, and intestinal obstruction. Intrauterine ultrasonography is necessary to differentiate ovarian cysts from these other possibilities.[19]

Aspiration of these cysts can be performed but is associated with complications, such as reformation of cyst, infection, and premature labor.[14]

Once the diagnosis of a fetal ovarian cyst is made, it is important to perform serial ultrasonographic examinations to detect any structural changes in size or appearance or complications, such as hydramnios, ascites, or torsion.[19]

Of these complications, ovarian torsion is the most serious complication of a fetal ovarian cyst and may manifest as fetal tachycardia due to peritoneal irritation.

Proper management includes serial ultrasonography to look for signs of regression or postnatal surgery if the cyst is complicated or larger than 5 cm in diameter.[14]

Previous
Next

Ovarian Cysts in Pregnancy

The corpus luteum is responsible for progesterone production during pregnancy and normally regresses at around 8 weeks’ gestation.[12]

Most pregnancy-associated cysts, such as corpus luteal and follicular cysts, resolve by gestational age 14-16 weeks and are hormonally responsive, allowing conservative management.[12] By gestational age 16-20 weeks, up to 96% of masses resolve spontaneously. Simple cysts smaller than 6 cm in diameter have a risk of malignancy of less than 1%.[23]

Corpus luteal cysts tend to be larger and more symptomatic than follicular cysts and are more prone to hemorrhage and rupture. Follicular cysts are usually smaller, with internal hemorrhage being relatively uncommon.

Masses that persist longer may warrant further workup for potential neoplastic disease based on clinical findings and radiologic evidence.[12] Serum CA125 studies are not recommended in pregnancy, as levels can fluctuate widely in normal pregnancy, particularly in the first and second trimesters, and can be elevated in many benign conditions. One group suggests observation, with postpartum surgery in select patients who have large, persistent adnexal masses in whom ultrasonographic findings are not highly suggestive of malignancy.[5] However, in situations in which cysts are symptomatic, including causing pain and discomfort, or with rapid growth on serial ultrasound, surgical removal should be considered.

If malignancy is a possibility and peripartum surgery is warranted, the risk of harming the pregnancy is weighed against a delay in treatment, but surgery is generally delayed until the mid-second trimester, when most cysts have resolved.[23]

Some ovarian conditions unique to pregnancy include the hyperstimulated ovary, ovarian hyperstimulation syndrome, hyperreactio luteinalis, theca-lutein cysts, and luteoma of pregnancy. Hyperstimulated ovaries represent a normal ovarian response to circulating hCG levels and are typically seen in women who have undergone ovulation induction.

Previous
Next

Postmenopausal Ovarian Cysts

Most studies estimate the prevalence of simple, unilocular adnexal cysts in asymptomatic, postmenopausal women at 3-18%, with most of these cysts being smaller than 5cm in diameter.

Early studies indicated the risk of malignancy for these asymptomatic adnexal cysts in postmenopausal patients to be as high as 7%, but subsequent studies showed the prevalence to be less than 1% in small cysts.[24]

In these patients, repeat ultrasonography at 4-6 weeks can be performed along with CA125 studies in an outpatient setting. Half of asymptomatic cysts smaller than 5 cm resolve in 2 months, but rising CA125 levels or increasing cyst size or complexity may warrant surgery.

Follow-up care is important, as the risk of an ovarian neoplasm being malignant rises from 13% in premenopausal patients to 45% in postmenopausal patients.[18]

Bilateral oophorectomy

Bilateral oophorectomy and, often, hysterectomy are performed in many postmenopausal women with ovarian cysts because of the increased incidence of neoplasms in this population.

Previous
Next

Transfer

When a female patient presents in the emergency department (ED) with abdominal pain and signs or symptoms of an intraperitoneal process of unclear etiology, transfer is indicated if any of the following conditions are met:

  • Backup surgical, obstetric, or gynecologic support is not available to the ED
  • Operative capacity is not available at the health-care delivery site
  • Imaging capacity is not available at the facility

Unstable patients should not be transferred unless the facility is truly unable to provide appropriate treatment or evaluation. The patient is the responsibility of the transferring physician until her arrival at the next hospital.

Previous
Next

Laparotomy and Laparoscopy

Persistent simple ovarian cysts larger than 5-10 cm, especially if symptomatic, and complex ovarian cysts should be considered for surgical removal.

The surgical approaches include an open incisional technique (laparotomy) and a minimally invasive technique (laparoscopy) with very small incisions. Whichever method is used, the goals remain the same; they include the following:

  • To confirm the diagnosis of an ovarian cyst
  • To assess whether the cyst appears to be malignant
  • To obtain fluid from peritoneal washings for cytologic assessment
  • To remove the entire cyst intact for pathologic analysis - This may mean removing the entire ovary
  • To assess the opposite ovary and other abdominal organs
  • To perform additional surgery as indicated

The use of laparoscopic techniques is becoming widespread, and the indications are extending. Laparoscopy is preferred to laparotomy when indicated because it has less adverse effects for the patient and leads to faster recovery.[42] However, it is essential that the disease outcome for the patient not be inferior to that achieved with laparotomy.[43]

Some patients, including those with chronic lung disease who are unable to tolerate a high intra-abdominal pressure or a steep head-down position, are unsuitable for laparoscopy. Others are unsuitable because of previous surgeries causing severe adhesions. For many situations the most important factor is the skill and experience of the surgeon.

With benign cysts there is no absolute contraindication to the use of laparoscopy. Such patients include those considered to have a dermoid cyst or endometrioma, those with functional or simple cysts that are causing symptoms and have not resolved with conservative management, and those presenting with acute symptoms. The aim should be to remove all cysts intact,[44, 45] but if this is not possible, the cyst and/or affected ovary may be placed in a protective bag that allows the cyst to be ruptured and drained without contamination prior to removal.

Malignant ovarian cysts associated with widespread disease are usually managed by laparotomy.

Some controversy surrounds the surgical approach for very large, benign-appearing ovarian cysts. The traditional approach for both was a long, midline incision in order to allow removal of the intact cyst and ovary. Some now promote a laparoscopic approach with drainage of the cyst, allowing the ovary to be removed through a small incision.[46] The down side to this is the potential for the cyst to spill cancer cells into the abdominal cavity. Laparoscopy is now used to remove small to medium-sized cancerous ovarian cysts (up to about 12 cm) and to stage ovarian cancer.

Excision of a benign cyst alone—such as a dermoid or functional cyst or an endometrioma—with conservation of the ovary may be performed in patients who desire retention of their ovaries for future fertility or for other reasons.

If the ovarian cyst is benign, removal of the opposite ovary should be considered in postmenopausal, perimenopausal, and premenopausal women older than 35 years who have completed their family and are considered at increased genetic risk for subsequent development of ovarian carcinoma. These indications are all relative, and the issues should be discussed with the patient prior to any surgery.

A gynecologic cancer specialist should be available to help with any patient who undergoes surgery for a potentially malignant ovarian cyst. Whenever possible, the patient should consult with the specialist prior to the surgery to allow all issues to be addressed. This will allow the appropriate surgery to be performed on patients found to have cancer.

Previous
Next

Deterrence and Prevention

The current use of oral contraceptive pills (OCPs) protects against the development of functional ovarian cysts. As previously mentioned, however, existing functional cysts do not regress more quickly when treated with combined oral contraceptives than they do with expectant management, so OCPs should not be used for that purpose.[7]

Current and previous use of OCPs within 15 years reduces the risk of epithelial ovarian cystadenocarcinoma.

There is no established consensus for recommending annual gynecologic examination, and its role is questionable in asymptomatic women older than 21 years.[47, 48]

No generalized screening test is available for ovarian cystadenocarcinoma, but women at high risk based on family history or a previous history of breast cancer should undergo an annual ultrasonographic examination and CA125 test. Referral for genetic counseling should be considered.

Women at high risk for ovarian cystadenocarcinoma may be offered prophylactic oophorectomy, which will prevent the development of ovarian cancer but not peritoneal carcinoma.

Previous
Next

Consultations

The following consultations should be made:

  • Infertility and reproductive endocrinologist - For endometrioma and polycystic ovarian syndrome
  • Gynecologic oncologist - For any complex ovarian cyst or adnexal mass, especially if the serum CA125 level is elevated above 35 U/mL and for patients with a strong family history of ovarian carcinoma
  • General surgeon - Consult a general surgeon in the ED when the clinical presentation indicates an intraperitoneal process that is not clearly obstetric or gynecologic
  • Obstetrician/gynecologist - When an ovarian-, uterine-, or pregnancy-related emergency is suspected

It is imperative to expedite hemodynamically unstable patients to the operating room, with consulting services mobilized, while the initial resuscitation in the ED is in progress.

Previous
Next

Long-Term Monitoring

The timing of outpatient care for patients with ovarian cysts depends on the specific patient’s age and pregnancy status. In pregnant patients, most ovarian cysts resolve at 16-20 weeks’ gestation.

Patients with benign-appearing ovarian cysts that are unilocular and smaller than 5-6 cm in diameter require no further follow-up for the cyst during pregnancy and require only routine prenatal visits. In nonpregnant patients and in patients following pregnancy, such cysts can be followed with serial ultrasound.

If the cyst is larger than 5-6 cm or is multicystic, the patient should undergo follow-up ultrasonography at 16 weeks' gestation to allow time for cyst resolution. Persistent complex masses may be further characterized by MRI, either during or after pregnancy, to search for distinctive features that would guide diagnosis.[12]

Ovarian cysts that are strongly suggestive of malignancy or that are larger than 8-10 cm in diameter, are symptomatic, or are at an increased risk for torsion, rupture, or obstruction of labor are more likely to require surgical intervention[49] ; they necessitate more urgent follow-up with an obstetrician and, possibly, a multidisciplinary approach in a timely fashion.

If surgery is required, it is most advantageous to perform it in the early second trimester, as the risk of spontaneous abortion during this period is lower than in the first trimester. It is better to avoid surgical intervention during the third trimester, if possible, to prevent inducing preterm delivery and to avoid technical issues in dealing with a larger uterus.

In postpartum patients, the size and complexity of the ovarian cyst and the CA125 level are used to determine management. Unilocular cysts that are smaller than 5 cm in diameter should be monitored with transvaginal ultrasonography and CA125 studies at 6-month intervals. Complex ovarian cysts that are smaller than 5 cm in diameter in the presence of normal CA125 levels (defined as < 35 U/mL) should be monitored in 4 weeks with repeat ultrasonography and CA125 studies. Surgery may be indicated for complex ovarian tumors that are smaller than 5 cm in diameter when CA125 levels are elevated (>35 U/mL) and for complex tumors larger than 5 cm in diameter.[18]

Studies have used various timeframes as indices for cyst resolution in nonpregnant, premenopausal patients. Most of these studies showed cyst resolution by 2-3 months, dictating ultrasonography with or without gynecologic follow-up in these patients.[41]

Previous
 
 
Contributor Information and Disclosures
Author

C William Helm, MBBCh, MA, FRCS(Edin), FRCS Consultant, Northern Gynaecological Oncology Centre, UK

C William Helm, MBBCh, MA, FRCS(Edin), FRCS is a member of the following medical societies: American College of Obstetricians and Gynecologists, International Gynecologic Cancer Society, European Society of Gynaecological Oncology

Disclosure: Nothing to disclose.

Specialty Editor Board

Nicole W Karjane, MD Associate Professor, Department of Obstetrics and Gynecology, Virginia Commonwealth University Medical Center

Nicole W Karjane, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, Association of Professors of Gynecology and Obstetrics, North American Society for Pediatric and Adolescent Gynecology

Disclosure: Nothing to disclose.

Chief Editor

Michel E Rivlin, MD Former Professor, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine

Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, Royal College of Surgeons of Edinburgh, Royal College of Obstetricians and Gynaecologists

Disclosure: Nothing to disclose.

Acknowledgements

Kimberly Duklewski Abel, MD Staff Physician, Department of Emergency Medicine, Franklin Memorial Hospital, Carilion Health System

Disclosure: Nothing to disclose.

Andrew A Aronson, MD, FACEP Vice President, Physician Practices, Bravo Health Advanced Care Center; Consulting Staff, Department of Emergency Medicine, Taylor Hospital, Ridley Park, Pennsylvania

Andrew A Aronson, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, Massachusetts Medical Society, and Society of Hospital Medicine

Disclosure: Nothing to disclose.

A David Barnes, MD, PhD, MPH, FACOG Consulting Staff, Department of Obstetrics and Gynecology, Mammoth Hospital (Mammoth Lakes, California), Pioneer Valley Hospital (Salt Lake City, Utah), Warren General Hospital (Warren, Pennsylvania), and Mountain West Hospital (Tooele, Utah)

A David Barnes, MD, PhD, MPH, FACOG is a member of the following medical societies: American College of Forensic Examiners, American College of Obstetricians and Gynecologists, American Medical Association, Association of Military Surgeons of the US, and Utah Medical Association

Disclosure: Nothing to disclose.

Pamela L Dyne, MD Professor of Clinical Medicine/Emergency Medicine, David Geffen School of Medicine at UCLA; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center

Pamela L Dyne, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

A Antoine Kazzi, MD Deputy Chief of Staff, American University of Beirut Medical Center; Associate Professor, Department of Emergency Medicine, American University of Beirut, Lebanon

A Antoine Kazzi, MD a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Mark A Silverberg, MD, FACEP, MMB Assistant Professor, Assistant Residency Director, Department of Emergency Medicine, State University of New York Downstate College of Medicine; Consulting Staff, Department of Emergency Medicine, Staten Island University Hospital, Kings County Hospital, University Hospital, State University of New York Downstate at Brooklyn

Mark A Silverberg, MD, FACEP, MMB is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Council of Emergency Medicine Residency Directors, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Dana A Stearns, MD Assistant Director of Undergraduate Education, Department of Emergency Medicine, Massachusetts General Hospital

Dana A Stearns, MD is a member of the following medical societies: American Academy of Emergency Medicine and American College of Emergency Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Drugs & Diseases Salary Employment

Walter W Valesky Jr, MD Clinical Assistant Instructor, Department of Emergency Medicine, State University of New York Downstate, Brooklyn

Disclosure: Nothing to disclose.

Mark Zwanger, MD, MBA Assistant Professor, Department of Emergency Medicine, Thomas Jefferson University

Mark Zwanger, MD, MBA is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and American Medical Association

Disclosure: Nothing to disclose.

References
  1. Bottomley C, Bourne T. Diagnosis and management of ovarian cyst accidents. Best Pract Res Clin Obstet Gynaecol. 2009 Oct. 23(5):711-24. [Medline].

  2. Lambert MJ, Villa M. Gynecologic ultrasound in emergency medicine. Emerg Med Clin North Am. 2004 Aug. 22(3):683-96. [Medline].

  3. Bailey CL, Ueland FR, Land GL, DePriest PD, Gallion HH, Kryscio RJ, et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol. 1998 Apr. 69(1):3-7. [Medline].

  4. Stany MP, Hamilton CA. Benign disorders of the ovary. Obstet Gynecol Clin North Am. 2008 Jun. 35(2):271-84, ix. [Medline].

  5. Schmeler KM, Mayo-Smith WW, Peipert JF, Weitzen S, Manuel MD, Gordinier ME. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol. 2005 May. 105(5 Pt 1):1098-103. [Medline].

  6. Roman LD. Small cystic pelvic masses in older women: is surgical removal necessary?. Gynecol Oncol. 1998 Apr. 69(1):1-2. [Medline].

  7. ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010 Jan. 115(1):206-18. [Medline].

  8. Knight JA, Lesosky M, Blackmore KM, Voigt LF, Holt VL, Bernstein L, et al. Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study. Breast Cancer Res Treat. 2008 May. 109(1):157-64. [Medline].

  9. Bosetti C, Scotti L, Negri E, Talamini R, Levi F, Franceschi S, et al. Benign ovarian cysts and breast cancer risk. Int J Cancer. 2006 Oct 1. 119(7):1679-82. [Medline].

  10. Clement PB. Anatomy and histology of the ovary. Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, NY: Springer-Verlag; 2002. 649-673.

  11. Katz VL. Comprehensive Gynecology. 5th ed. Philadelphia: Mosby Elsevier.; 2007. 1098-103.

  12. Glanc P, Salem S, Farine D. Adnexal masses in the pregnant patient: a diagnostic and management challenge. Ultrasound Q. 2008 Dec. 24(4):225-40. [Medline].

  13. Caruso PA, Marsh MR, Minkowitz S, Karten G. An intense clinicopathologic study of 305 teratomas of the ovary. Cancer. 1971 Feb. 27(2):343-8. [Medline].

  14. Heling KS, Chaoui R, Kirchmair F, Stadie S, Bollmann R. Fetal ovarian cysts: prenatal diagnosis, management and postnatal outcome. Ultrasound Obstet Gynecol. 2002 Jul. 20(1):47-50. [Medline].

  15. Wyshak G, Frisch RE, Albright TE, Albright NL, Schiff I. Smoking and cysts of the ovary. Int J Fertil. 1988 Nov-Dec. 33(6):398-404. [Medline].

  16. Holt VL, Cushing-Haugen KL, Daling JR. Risk of functional ovarian cyst: effects of smoking and marijuana use according to body mass index. Am J Epidemiol. 2005 Mar 15. 161(6):520-5. [Medline].

  17. Holt VL, Cushing-Haugen KL, Daling JR. Oral contraceptives, tubal sterilization, and functional ovarian cyst risk. Obstet Gynecol. 2003 Aug. 102(2):252-8. [Medline].

  18. McDonald JM, Modesitt SC. The incidental postmenopausal adnexal mass. Clin Obstet Gynecol. 2006 Sep. 49(3):506-16. [Medline].

  19. Kwak DW, Sohn YS, Kim SK, Kim IK, Park YW, Kim YH. Clinical experiences of fetal ovarian cyst: diagnosis and consequence. J Korean Med Sci. 2006 Aug. 21(4):690-4. [Medline]. [Full Text].

  20. American Cancer Society. Cancer Facts and Figures 2009. Estimated New Cancer Cases and Deaths by Sex, US, 2009. American Cancer Society. Available at http://www.cancer.org/docroot/stt/stt_0.asp?from=fast. Accessed: December 24, 2009.

  21. Sykes PH, Quinn MA, Rome RM. Ovarian tumors of low malignant potential: a retrospective study of 234 patients. Int J Gynecol Cancer. 1997. 7:218-26.

  22. Miller BA, Kolonel LN, Bernstein L, et al. Racial/Ethnic Patterns of Cancer in the United States 1988-1992. National Cancer Institute. 1996.

  23. Giuntoli RL 2nd, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 2006 Sep. 49(3):492-505. [Medline].

  24. Castillo G, Alcazar JL, Jurado M. Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women. Gynecol Oncol. 2004 Mar. 92(3):965-9. [Medline].

  25. Committee opinion no. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer. Obstet Gynecol. 2011 Mar. 117(3):742-6. [Medline].

  26. Jacobs I, Bast RC Jr. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod. 1989 Jan. 4(1):1-12. [Medline].

  27. Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y. Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res. 2008 Feb 15. 14(4):1065-72. [Medline].

  28. McIntosh M, Anderson G, Drescher C, Hanash S, Urban N, Brown P. Ovarian cancer early detection claims are biased. Clin Cancer Res. 2008 Nov 15. 14(22):7574; author reply 7577-9. [Medline].

  29. Greene MH, Feng Z, Gail MH. The importance of test positive predictive value in ovarian cancer screening. Clin Cancer Res. 2008 Nov 15. 14(22):7574; author reply 7577-9. [Medline].

  30. Bast RC Jr, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, et al. New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005 Nov-Dec. 15 Suppl 3:274-81. [Medline].

  31. Osmers R. Sonographic evaluation of ovarian masses and its therapeutical implications [editorial]. Ultrasound Obstet Gynecol. 1996 Oct. 8(4):217-22. [Medline].

  32. Loyer EM, Whitman GJ, Fenstermacher MJ. Imaging of ovarian carcinoma. Int J Gynecol Cancer. 1999 Sep. 9(5):351-361. [Medline].

  33. Vandermeer FQ, Wong-You-Cheong JJ. Imaging of acute pelvic pain. Clin Obstet Gynecol. 2009 Mar. 52(1):2-20. [Medline].

  34. Chan L, Lin WM, Uerpairojkit B, Hartman D, Reece EA, Helm W. Evaluation of adnexal masses using three-dimensional ultrasonographic technology: preliminary report. J Ultrasound Med. 1997 May. 16(5):349-54. [Medline].

  35. Kupesic S, Plavsic BM. Early ovarian cancer: 3-D power Doppler. Abdom Imaging. 2006 Sep-Oct. 31(5):613-9. [Medline].

  36. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009 Apr. 10(4):327-40. [Medline].

  37. Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, et al. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol. 2009 Apr. 113(4):775-82. [Medline]. [Full Text].

  38. Higgins RV, Matkins JF, Marroum MC. Comparison of fine-needle aspiration cytologic findings of ovarian cysts with ovarian histologic findings. Am J Obstet Gynecol. 1999 Mar. 180(3 Pt 1):550-3. [Medline].

  39. Moran O, Menczer J, Ben-Baruch G, et al. Cytologic examination of ovarian cyst fluid for the distinction between benign and malignant tumors. Obstet Gynecol. 1993 Sep. 82(3):444-6. [Medline].

  40. Lu D, Davila RM, Pinto KR, Lu DW. ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses. Diagn Cytopathol. 2004 May. 30(5):320-4. [Medline].

  41. Grimes DA, Jones LB, Lopez LM, Schulz KF. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev. 2009 Apr 15. CD006134. [Medline].

  42. Medeiros LR, Rosa DD, Bozzetti MC, Fachel JM, Furness S, Garry R, et al. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev. 2009 Apr 15. CD004751. [Medline].

  43. Maiman M. Laparoscopic removal of the adnexal mass: the case for caution. Clin Obstet Gynecol. 1995 Jun. 38(2):370-9. [Medline].

  44. Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet. 2001 Jan 20. 357(9251):176-82. [Medline].

  45. Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, et al. Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol. 2009 Jan. 113(1):11-7. [Medline].

  46. Eltabbakh GH, Charboneau AM, Eltabbakh NG. Laparoscopic surgery for large benign ovarian cysts. Gynecol Oncol. 2008 Jan. 108(1):72-6. [Medline].

  47. [Guideline] Qaseem A, Humphrey LL, Harris R, Starkey M, Denberg TD. Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014 Jul 1. 161(1):67-72. [Medline].

  48. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. Committee opinion no. 534: well-woman visit. Obstet Gynecol. 2012 Aug. 120(2 Pt 1):421-4. [Medline]. [Full Text].

  49. Leiserowitz GS. Managing ovarian masses during pregnancy. Obstet Gynecol Surv. 2006 Jul. 61(7):463-70. [Medline].

  50. International Federation of Gynecology and Obstetrics. Annual Report on the Results of Treatment in Gynaecological Cancer. J Epidemiol Biostat. 1998. 3:1-68.

  51. Pavlik EJ, Ueland FR, Miller RW. Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol. Aug 2013;122(2):210-7. Available at http://journals.lww.com/greenjournal/pages/articleviewer.aspx?year=2013&issue=08000&article=00005&type=abstract. Accessed: Aug 13 2013.

 
Previous
Next
 
A multilocular right ovarian cyst that is 24 cm in diameter. It is seen with the adjacent fallopian tube and uterus. The infundibulo-pelvic ligament carrying the ovarian artery and vein has been divided. Histology reported a mucinous cystadenocarcinoma of low malignant potential. Image courtesy of C. William Helm, MBBChir.
Transabdominal sonogram of a multilocular right ovarian cyst that is 24 cm in diameter, with the adjacent fallopian tube and uterus. The infundibulo-pelvic ligament carrying the ovarian artery and vein has been divided. This sonogram demonstrates a large, complex cystic mass with vascularity within the septations. Red and blue colors show blood flow towards and away from the transducer. The resistive index was low. Histology reported a mucinous cystadenocarcinoma of low malignant potential. Courtesy Patrick O'Kane, MD.
A multilocular right ovarian cyst that is 24 cm in diameter has been removed and cut open. It has a smooth surface and a multicystic internal structure. Image courtesy of C. William Helm, MBBChir.
An ovarian cyst that underwent torsion (twisting of the vascular pedicle). The patient presented with a short history of severe lower abdominal pain. The twisted pedicle can be seen attached to the cyst, which has turned dusky due to ischemia. No viable epithelial lining was available for histologic diagnosis. Image courtesy of C. William Helm, MBBChir.
Endovaginal sonogram shows a striking echogenic mass lateral to the uterus, with posterior acoustic shadowing giving a "tip-of-the-iceberg" appearance. This is pathognomonic for a dermoid cyst. Occasionally, this appearance may be mistaken for a gas-filled bowel. Courtesy of Patrick O'Kane, MD.
A dermoid cyst (mature cystic teratoma) after opening the abdomen. Note the yellowish color of the contents seen through the wall. Image courtesy of C. William Helm, MBBChir.
A dermoid cyst has been opened in the operating room to reveal copious sebaceous fluid. This cyst also contained hair. Image courtesy of C. William Helm, MBBChir.
A dermoid cyst has been opened and contains teeth. Image courtesy of C. William Helm, MBBChir.
Theca-lutein cysts replacing an ovary in a patient with a molar pregnancy. Despite their size these cysts are benign and usually resolve after treatment of the underlying disease. Image courtesy of C. William Helm, MBBChir.
Cross-section of a clear cell carcinoma of the ovary. Note the cystic spaces intermingled with solid areas. Image courtesy of C. William Helm, MBBChir.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.